CARGO Therapeutics, Free Cash Flow Over Time
| CRGX Stock | 16.42 0.19 1.17% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out CARGO Therapeutics, Performance and CARGO Therapeutics, Correlation. CARGO |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CARGO Therapeutics,. If investors know CARGO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CARGO Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.59) | Return On Assets (0.40) | Return On Equity (0.70) |
The market value of CARGO Therapeutics, is measured differently than its book value, which is the value of CARGO that is recorded on the company's balance sheet. Investors also form their own opinion of CARGO Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is CARGO Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CARGO Therapeutics,'s market value can be influenced by many factors that don't directly affect CARGO Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CARGO Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CARGO Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CARGO Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Free Cash Flow Analysis
Compare CARGO Therapeutics, and related stocks such as Fossil Group, Saia Inc, and Mitsubishi UFJ Lease Free Cash Flow Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FOSL | 4.6 M | 119.8 M | 328.8 M | 301.6 M | 283.7 M | 277.3 M | 144.5 M | 152.5 M | 230.2 M | (38.4 M) | 90.5 M | 39.7 M | (124.1 M) | (69.4 M) | (65.9 M) |
| SAIA | 20.6 M | (12.7 M) | 14.6 M | (25 M) | 4.4 M | 56.2 M | 26.4 M | (28.9 M) | 32.8 M | (14.8 M) | 78 M | 96.8 M | 105.6 M | 138.1 M | 145 M |
| WSC | 83.1 M | 83.1 M | 83.1 M | 83.1 M | 83.1 M | (64.6 M) | (71 M) | (117.5 M) | (128.4 M) | (40.9 M) | 116 M | 230.9 M | 257.9 M | 512 M | 537.6 M |
| HEES | 30.1 M | (85.3 M) | (264.6 M) | (158.3 M) | (243.4 M) | 1.1 M | (25.6 M) | (30.5 M) | (204.3 M) | (33.5 M) | 151 M | (193.1 M) | (202.6 M) | (340.3 M) | (323.3 M) |
| HRI | (16.8 M) | 2.3 B | (406.7 M) | (162.1 M) | (189 M) | (189 M) | (66.4 M) | (234.3 M) | (289.9 M) | (59.7 M) | 225.4 M | 102.2 M | (355.5 M) | (390 M) | (370.5 M) |
| HTZ | (11.7 B) | (7.5 B) | (7.2 B) | (7 B) | (8.2 B) | (9.7 B) | (8.6 B) | (8.4 B) | (10.1 B) | (11 B) | (4.7 B) | (5.4 B) | (8.2 B) | (7.2 B) | (7.6 B) |
CARGO Therapeutics, and related stocks such as Fossil Group, Saia Inc, and Mitsubishi UFJ Lease Free Cash Flow description
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.My Equities
My Current Equities and Potential Positions
| CARGO Therapeutics, Common | CRGX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
null 16.42
Additional Tools for CARGO Stock Analysis
When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.